Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/14/2008WO2008095943A1 The use of 7-azaindoles in the inhibition of c-jun n-terminal kinase
08/14/2008WO2008095912A2 Enantiopure pharmacologically active tricyclic benzimidazoles
08/14/2008WO2008095908A1 1-benzenesulfonyl-1h-indole derivatives as inhibitors of ccr9 activity
08/14/2008WO2008095852A1 Bronchorelaxing arylamides
08/14/2008WO2008095847A1 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
08/14/2008WO2008095841A2 Nitric oxide donor compounds
08/14/2008WO2008095835A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors
08/14/2008WO2008095823A1 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
08/14/2008WO2008095821A1 Indol-2-yl-piperazin-1-yl-methanone derivatives
08/14/2008WO2008095820A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity
08/14/2008WO2008095809A1 Nitric oxide releasing steroids
08/14/2008WO2008095808A1 Nitric oxide releasing steroids
08/14/2008WO2008095806A1 Nitric oxide releasing steroids
08/14/2008WO2008095773A1 Use of flibanserin for the treatment of insomnia
08/14/2008WO2008095689A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
08/14/2008WO2008095679A1 Use of bartonella quintana derived lipopolysaccharide for the treatment of autoimmune, autoinflammatory or infectious diseases
08/14/2008WO2008095597A2 Transdermal therapeutic system for administering water-soluble active ingredients
08/14/2008WO2008095588A1 Composition comprising chitosan and an acidic drug for oral controlled release
08/14/2008WO2008095479A2 Use of a highly emulsified silicone oil (hes) for the production of a medicament
08/14/2008WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof
08/14/2008WO2008095328A1 A kind of hydrochloric piperphentonamine freeze-dried powder injection, preparation methods and uses thereof
08/14/2008WO2008095297A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission
08/14/2008WO2008095293A1 [1,2,3] triazolyl substituted coumarins as inhibitors of leukotriene biosynthesis
08/14/2008WO2008095292A1 [1,2,3] triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
08/14/2008WO2008095284A1 Fast-disintegrating epinephrine tablets for buccal or sublingual administration
08/14/2008WO2008095275A1 Methods for the treatment of senile dementia of the alzheimer's type
08/14/2008WO2008095253A1 Treatment of adhd
08/14/2008WO2008095221A1 Treatment of adhd
08/14/2008WO2008079972A3 4-{4- [ ({3-tert-butyl-1- [3- (hydroxymethyl) phenyl] - 1h- pyrazol- 5 -yl } carbamoyl) -amin o] -3-chlorophenoxy} -n-methylpyridine-2-carboxamide as an inhibitor of the vegfr kinase for the treatment of cancer
08/14/2008WO2008079610A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
08/14/2008WO2008077939A3 Duloxetine composition
08/14/2008WO2008077885A3 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
08/14/2008WO2008077092A3 Combined effects of topiramate and ondansetron on alcohol consumption
08/14/2008WO2008076810A3 Azabicyclic heterocycles as cannabinoid receptor modulators
08/14/2008WO2008076805A3 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
08/14/2008WO2008076805A2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
08/14/2008WO2008075320A3 Antilipidemic pharmaceutical compositions and process for preparation thereof
08/14/2008WO2008075173A3 Methods for treating podocyte-related disorders
08/14/2008WO2008075149A3 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia
08/14/2008WO2008073350A3 Acetylene derivatives and their use for binding and imaging amyloid plaques
08/14/2008WO2008072206A3 Composition comprising pyrithione or a polyvalent metal salt of a pyrithione and furametpyr
08/14/2008WO2008071870A3 Use of agomelatine in order to obtain drugs intended for the treatment of smith-magenis syndrome
08/14/2008WO2008071869A3 Use of agomelatine in order to obtain drugs intended for the treatment of periventricular leukomalacia
08/14/2008WO2008070583A3 Thrombopoietin mimetics
08/14/2008WO2008070346A9 Methods for treating pain with reduced nuasea and vomiting
08/14/2008WO2008070100A8 Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
08/14/2008WO2008069069A8 Amide compound and salt thereof, and biofilm formation inhibitor or biofilm remover using the same
08/14/2008WO2008067390A9 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof
08/14/2008WO2008067060A3 Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue
08/14/2008WO2008067039A3 Colchicine neoglycosides and methods for their synthesis and use
08/14/2008WO2008064255A3 Compounds modulating c-fms and/or c-kit activity and uses therefor
08/14/2008WO2008064255A2 Compounds modulating c-fms and/or c-kit activity and uses therefor
08/14/2008WO2008064093A3 Salts and crystal forms of 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile
08/14/2008WO2008063984A3 Allosteric modulators of the a1 adenosine receptor
08/14/2008WO2008062446A3 An extended release composition of levetiracetam, which exhibits no adverse food effect
08/14/2008WO2008062426A3 Formulation of benzazepine derivatives
08/14/2008WO2008060949A3 Compounds with anti-androgenic activity and the use thereof
08/14/2008WO2008057363A3 Use of vitamin d derivatives to enhance delivery of therapeutics and oxygen to tumors
08/14/2008WO2008054545A3 Method of inhibiting the transmission of viruses
08/14/2008WO2008051558A3 Isolated hydroxy and n-oxide metabolites and derivatives of o-desmethylvenlafaxine and methods of treatment
08/14/2008WO2008051557A3 Methods and compositions for treatment of skin conditions
08/14/2008WO2008049855A3 7-azaindole derivatives as c-met kinase inhibitors
08/14/2008WO2008048540A3 2-hydroxy-2-phenyl/thiophenyl propionamides as androgen receptor modulators
08/14/2008WO2008046994A8 Novel composition and uses thereof, in particular cosmetic uses, for treating skin dehydration
08/14/2008WO2008046168A3 Triglyceridic nature oil with improved nutritional properties and process for the preparation thereof
08/14/2008WO2008044054A3 Hydroxy-substituted benzoic acid amide compounds for use in therapy
08/14/2008WO2008042480A3 Epoxide inhibitors of cysteine proteases
08/14/2008WO2008041176A3 Process for the preparation of form i and form ii of ritonavir
08/14/2008WO2008041140A3 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
08/14/2008WO2008039087A3 Indoline derivatives and uses thereof
08/14/2008WO2008038136A3 Substituted heterocyclylcarbonylamino-acetic-acid-derivatives as inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors
08/14/2008WO2008033475A3 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions
08/14/2008WO2008033468A3 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism
08/14/2008WO2008029096A8 P53 activating benzoyl urea and benzoyl thiourea compounds
08/14/2008WO2008028903A3 Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
08/14/2008WO2008024914A3 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
08/14/2008WO2008024398B1 Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
08/14/2008WO2008023390B1 Modified release pharmaceutical composition of bupropion hydrochloride
08/14/2008WO2008022256A3 Methods and compositions for preventing or treating age-related diseases
08/14/2008WO2008020420A3 Compositions comprising calcium citrate malate and methods for making the same
08/14/2008WO2008019292A3 Compositions and methods for potentiating antibiotic activity
08/14/2008WO2008017074A3 Dyes and precursors and conjugates thereof
08/14/2008WO2008013913A8 Method and device for minimally invasive site specific ocular drug delivery
08/14/2008WO2008011513A3 Compounds and methods of modulating angiogenesis
08/14/2008WO2008010984A3 Acridine activation of p53 and uses thereof
08/14/2008WO2008007262A3 Bisnaphthalimidopropyl derivative compounds with anti-parasite and anti-cancer activity
08/14/2008WO2008007210A3 Nitrogenous n-substituted 4-spiro-heterocyclic 2, 2 -dimethylchromane derivatives
08/14/2008WO2008002594A3 Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
08/14/2008WO2008001306A3 Streptomycete and bioactive compound produced thereby
08/14/2008WO2007146293A3 Improved composition and method for taste masking
08/14/2008WO2007145993A3 Modified compositions and methods for enhancing brain function
08/14/2008WO2007145656A3 Cefquinome compositions and methods of their use
08/14/2008WO2007140181A3 Combination therapy comprising an adenosine uptake inhibitor and a non-selective adenosine receptor antagonist
08/14/2008WO2007139847A3 Method of enhancing the control of viruses on skin
08/14/2008WO2007132359A3 Composition containing lactobacillus sp. and a cannabinoid receptor and/or a opioid receptor agonist
08/14/2008WO2007121416A3 Chemical compounds
08/14/2008WO2007112414A3 Conjugated double strand compositions for use in gene modulation
08/14/2008WO2007110694A3 Gelling hydrophobic injectable polymer compositions
08/14/2008WO2007109786A3 Process for the preparation of 3,4-disubstituted-thiazolidin-2-ones
08/14/2008WO2007106561A3 Prevention and treatment of cancer and other diseases
1 ... 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 ... 7860